Related Experiment Video
Updated: Jan 1, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.5K
Endometrial cancer and its cell lines
Kristijan Skok1,2, Uroš Maver3,4, Lidija Gradišnik3
1Faculty of Medicine, Institute of Biomedical Sciences, University of Maribor, Taborska Ulica 8, SI-2000, Maribor, Slovenia. kristijan.skok@gmail.com.
Molecular Biology Reports
|December 19, 2019
Summary
This review highlights the critical need for accurate endometrial cancer cell line (CL) studies. Recognizing and addressing CL variability is essential for improving the reproducibility of preclinical cancer research.
Area of Science:
- Gynecological Oncology
- Cancer Cell Biology
- Translational Research
Background:
- Endometrial cancer is a prevalent gynecological malignancy globally.
- Cell lines (CLs) are vital in vitro models for investigating cancer biology and developing therapies.
- Recent studies reveal inconsistencies in CL nomenclature and culturing practices.
Purpose of the Study:
- To provide a comprehensive overview of current literature on endometrial cancer CLs.
- To emphasize the significance of rigorous CL studies in cancer research.
- To offer updated findings and recommendations for CL culturing.
Main Methods:
- A systematic literature analysis of over 60 articles from PubMed and Medline databases.
- Inclusion of primary studies detailing the origin of specific CLs.
- Focus on research published within the last 10 years in indexed journals.
Main Results:
- Cell lines are extensively utilized as in vitro tumor models.
- Significant variations exist across CL strains due to genomic evolution.
- Inconsistencies in CL nomenclature and culturing methods have been identified.
Conclusions:
- Genomic evolution causes substantial variability in CL strains, impacting research reproducibility.
- Laboratories must adopt advanced characterization techniques to manage CL variability.
- Improving CL characterization presents an opportunity to enhance preclinical cancer research reproducibility.
Related Concept Videos
01:16Cell Lines
9.9K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
9.9K
02:12What is Cancer?
13.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
13.8K
02:30Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K